Formas cristalinas de un inhibidor del Factor Xa
Una forma cristalina del maleato de betrixabán que tiene: i) un patrón de difracción de rayos X en polvo parecido al patrón de difracción de rayos X en polvo mostrado en la Figura 2 o 3; o iv) una estructura de celda unitaria con los siguientes parámetros de la celda a 100 K: a >= 8,284 Å, b >...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | MARGELEFSKY, Eric CAPODANNO, Vincent WENSLOW, Robert MAHER, Timothy ARROYO, Itzia Zoraida CORCORAN, Liam McNEVIN, Michael BALL, Richard PANDEY, Anjali |
description | Una forma cristalina del maleato de betrixabán que tiene: i) un patrón de difracción de rayos X en polvo parecido al patrón de difracción de rayos X en polvo mostrado en la Figura 2 o 3; o iv) una estructura de celda unitaria con los siguientes parámetros de la celda a 100 K: a >= 8,284 Å, b >= 18,082 Å, c >= 18,681 Å, α >= 71,22 º, ß >= 86,76 º, γ >= 89,69 º, y V >= 2645 A3; o v) una estructura de celda unitaria con los siguientes parámetros de la celda a 273 K: a >= 8,419 Å, b >= 18,113 Å, c >= 18,73 Å, α >= 71,14 º, ß >= 86,71 º, γ >= 89,31 º, y V >= 2699 A3.
Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2603084TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2603084TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2603084TT33</originalsourceid><addsrcrecordid>eNrjZDBwyy_KTSxWSC7KLC5JzMnMA7JTUhVK8xQy8zIykzJT8ouA_BwFt8TkEiAzIpGHgTUtMac4lRdKczMourmGOHvophbkx6cWFyQmp-allsS7BhuZGRgbWJiEhBgbE6MGADAkKx0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Formas cristalinas de un inhibidor del Factor Xa</title><source>esp@cenet</source><creator>MARGELEFSKY, Eric ; CAPODANNO, Vincent ; WENSLOW, Robert ; MAHER, Timothy ; ARROYO, Itzia Zoraida ; CORCORAN, Liam ; McNEVIN, Michael ; BALL, Richard ; PANDEY, Anjali</creator><creatorcontrib>MARGELEFSKY, Eric ; CAPODANNO, Vincent ; WENSLOW, Robert ; MAHER, Timothy ; ARROYO, Itzia Zoraida ; CORCORAN, Liam ; McNEVIN, Michael ; BALL, Richard ; PANDEY, Anjali</creatorcontrib><description>Una forma cristalina del maleato de betrixabán que tiene: i) un patrón de difracción de rayos X en polvo parecido al patrón de difracción de rayos X en polvo mostrado en la Figura 2 o 3; o iv) una estructura de celda unitaria con los siguientes parámetros de la celda a 100 K: a >= 8,284 Å, b >= 18,082 Å, c >= 18,681 Å, α >= 71,22 º, ß >= 86,76 º, γ >= 89,69 º, y V >= 2645 A3; o v) una estructura de celda unitaria con los siguientes parámetros de la celda a 273 K: a >= 8,419 Å, b >= 18,113 Å, c >= 18,73 Å, α >= 71,14 º, ß >= 86,71 º, γ >= 89,31 º, y V >= 2699 A3.
Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170223&DB=EPODOC&CC=ES&NR=2603084T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170223&DB=EPODOC&CC=ES&NR=2603084T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MARGELEFSKY, Eric</creatorcontrib><creatorcontrib>CAPODANNO, Vincent</creatorcontrib><creatorcontrib>WENSLOW, Robert</creatorcontrib><creatorcontrib>MAHER, Timothy</creatorcontrib><creatorcontrib>ARROYO, Itzia Zoraida</creatorcontrib><creatorcontrib>CORCORAN, Liam</creatorcontrib><creatorcontrib>McNEVIN, Michael</creatorcontrib><creatorcontrib>BALL, Richard</creatorcontrib><creatorcontrib>PANDEY, Anjali</creatorcontrib><title>Formas cristalinas de un inhibidor del Factor Xa</title><description>Una forma cristalina del maleato de betrixabán que tiene: i) un patrón de difracción de rayos X en polvo parecido al patrón de difracción de rayos X en polvo mostrado en la Figura 2 o 3; o iv) una estructura de celda unitaria con los siguientes parámetros de la celda a 100 K: a >= 8,284 Å, b >= 18,082 Å, c >= 18,681 Å, α >= 71,22 º, ß >= 86,76 º, γ >= 89,69 º, y V >= 2645 A3; o v) una estructura de celda unitaria con los siguientes parámetros de la celda a 273 K: a >= 8,419 Å, b >= 18,113 Å, c >= 18,73 Å, α >= 71,14 º, ß >= 86,71 º, γ >= 89,31 º, y V >= 2699 A3.
Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBwyy_KTSxWSC7KLC5JzMnMA7JTUhVK8xQy8zIykzJT8ouA_BwFt8TkEiAzIpGHgTUtMac4lRdKczMourmGOHvophbkx6cWFyQmp-allsS7BhuZGRgbWJiEhBgbE6MGADAkKx0</recordid><startdate>20170223</startdate><enddate>20170223</enddate><creator>MARGELEFSKY, Eric</creator><creator>CAPODANNO, Vincent</creator><creator>WENSLOW, Robert</creator><creator>MAHER, Timothy</creator><creator>ARROYO, Itzia Zoraida</creator><creator>CORCORAN, Liam</creator><creator>McNEVIN, Michael</creator><creator>BALL, Richard</creator><creator>PANDEY, Anjali</creator><scope>EVB</scope></search><sort><creationdate>20170223</creationdate><title>Formas cristalinas de un inhibidor del Factor Xa</title><author>MARGELEFSKY, Eric ; CAPODANNO, Vincent ; WENSLOW, Robert ; MAHER, Timothy ; ARROYO, Itzia Zoraida ; CORCORAN, Liam ; McNEVIN, Michael ; BALL, Richard ; PANDEY, Anjali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2603084TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MARGELEFSKY, Eric</creatorcontrib><creatorcontrib>CAPODANNO, Vincent</creatorcontrib><creatorcontrib>WENSLOW, Robert</creatorcontrib><creatorcontrib>MAHER, Timothy</creatorcontrib><creatorcontrib>ARROYO, Itzia Zoraida</creatorcontrib><creatorcontrib>CORCORAN, Liam</creatorcontrib><creatorcontrib>McNEVIN, Michael</creatorcontrib><creatorcontrib>BALL, Richard</creatorcontrib><creatorcontrib>PANDEY, Anjali</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MARGELEFSKY, Eric</au><au>CAPODANNO, Vincent</au><au>WENSLOW, Robert</au><au>MAHER, Timothy</au><au>ARROYO, Itzia Zoraida</au><au>CORCORAN, Liam</au><au>McNEVIN, Michael</au><au>BALL, Richard</au><au>PANDEY, Anjali</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Formas cristalinas de un inhibidor del Factor Xa</title><date>2017-02-23</date><risdate>2017</risdate><abstract>Una forma cristalina del maleato de betrixabán que tiene: i) un patrón de difracción de rayos X en polvo parecido al patrón de difracción de rayos X en polvo mostrado en la Figura 2 o 3; o iv) una estructura de celda unitaria con los siguientes parámetros de la celda a 100 K: a >= 8,284 Å, b >= 18,082 Å, c >= 18,681 Å, α >= 71,22 º, ß >= 86,76 º, γ >= 89,69 º, y V >= 2645 A3; o v) una estructura de celda unitaria con los siguientes parámetros de la celda a 273 K: a >= 8,419 Å, b >= 18,113 Å, c >= 18,73 Å, α >= 71,14 º, ß >= 86,71 º, γ >= 89,31 º, y V >= 2699 A3.
Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | spa |
recordid | cdi_epo_espacenet_ES2603084TT3 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Formas cristalinas de un inhibidor del Factor Xa |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T20%3A11%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MARGELEFSKY,%20Eric&rft.date=2017-02-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2603084TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |